They keep conflating this idea that the MIA means US patients can ship their tumors to advent and Advent can ship the drug which is clearly not the case. But pumpers pump BS.
The only way a US patient is going to get it is if they go to the UK and get treated there. Simple. And it would be all out of pocket. Not sure what is so hard to comprehend about that.
Artisan method is not the future and no one wants to invest a bunch of money into dedicated space that is expensive to maintain when it won’t be needed very long. Buildout plans from here on out will almost certainly be with Flaskworks and someone’s existing clean room space might be utilized for manufacturing artisan L if needed for the time being depending on when Flaskworks is expected to be certified and ready for fitting out in the UK and US. That’s where Charles River Labs and their international footprint might come in. Best wishes.
Market Data 
Markets 
AI
